Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples